Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson's Disease Foundation Invests in Next Generation of Physical Therapy Leaders

PDF Launches Innovative Pilot Training Program for Physical Therapy Educators

The Parkinson's Disease Foundation® (PDF®) is pleased to announce the launch of the Physical Therapy Faculty Program to improve care for the nearly one million people in the United States living with Parkinson’s disease. The pilot program launched this week in Boston, MA.

It is estimated that the number of people with Parkinson's disease may double by 2030. Research suggests that physical therapy and exercise can help people with Parkinson’s to maintain and improve mobility and to experience a better quality of life. Yet physical therapists have reported the need for better training to care for those living with Parkinson’s disease.

The Physical Therapy Faculty Program at PDF is a pilot “train the trainer” program that educates physical therapy faculty leaders who can, in turn, prepare their students to care for people with Parkinson’s. Participants in this week’s pilot program underwent an intensive training that included academic instruction, hands-on experience with people living with the disease, and mentorship from physical therapists who specialize in Parkinson's research and care.

"The Physical Therapy Faculty Program at PDF recognizes that physical therapy educators are in a unique position to help shape the future of Parkinson’s care — by reaching the next generation of practitioners. We are thrilled to launch the program, and welcome the first of our participants, who are already designing innovative curriculums that will change the landscape of physical therapy care and education in Parkinson’s disease,” said Terry Ellis, P.T., Ph.D., N.C.S., Manager of the Physical Therapy Faculty Program at PDF, Assistant Professor in the Department of Physical Therapy and Athletic Training at Boston University’s College of Health and Rehabilitation Sciences: Sargent College, and Director of the Center for Neurorehabilitation at Boston University.

"At PDF, our strategy is to mobilize a team of leaders in research, health care and the patient community to work together to end Parkinson's disease. As we look at the needs of our growing community — one which can greatly benefit from multidisciplinary care — we know that physical therapists are critical to our team," added Robin Anthony Elliott, CEO of PDF.

Participants are now prepared to care for people with Parkinson's, design teaching methods for students, integrate learning into community settings and conduct patient-centric research to improve physical therapy care in Parkinson's. They will continue to collaborate with PDF to advance research, care and physical therapy education in Parkinson's disease.

The Physical Therapy Faculty Program at PDF will expand to additional sites in 2017. Those who are accepted can earn up to 39 Continuing Competence Units (CCUs).

About Parkinson's Disease (PD)
Parkinson's disease is a progressive neurological disorder that affects nearly one million people in the US and over 10 million worldwide. Parkinson’s is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the US. It is associated with a loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety). Although promising research is being conducted, there is currently no cure for Parkinson's disease.

About Health Leadership at PDF
As part of the Parkinson's Disease Foundation® (PDF®) strategy to end Parkinson's, PDF mobilizes leaders in the health community to help us more quickly solve, treat and end the disease. Through innovative clinical training and online programs, PDF and its health leaders are playing an integral role in shaping multidisciplinary research and care and influencing national standards for health professional education. These programs include the Movement Disorders Clinical Training Program, which has trained 150 doctors trained to date, making PDF the largest private funder of training for early-career neurologists to specialize in Parkinson’s; the Edmond J. Safra Foundation Visiting Nurse Faculty Program at PDF, through which PDF has trained 190 nurse faculty leaders; and the newly-launched Physical Therapy Faculty Program, which aims to train 40 physical therapy educators by 2019. PDF also supports health leaders on the frontlines, by arming those in the nursing, physical therapy, occupational therapy and speech-language pathology fields with the tools they need to stay informed and support their patients. PDF offerings include free continuing education opportunities and patient education materials. In 2016, PDF is investing $600,000 for health leadership programs.

Thursday, August 4, 2016
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.